Role of samital in the prevention and treatment of chemo-radiotherapy-induced oral mucositis in head and neck carcinoma: a phase 2, randomized, double-blind, placebo-controlled clinical trial (rosam)

HIGHLIGHTS

  • who: Elena Fasanaro et al. from the , Padova, Italy have published the article: Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM), in the Journal: (JOURNAL)
  • what: The aim of this clinical study was to evaluate the role of SAMITAL in reducing the incidence of severe mucositis induced by concurrent chemo-radiotherapy; the secondary aims were the tolerability and patient-reported quality of life measures. Treatment was continued until discontinuation for one of the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?